219 related articles for article (PubMed ID: 10168093)
1. Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analyses.
Henry JA; Rivas CA
Pharmacoeconomics; 1997 Jun; 11(6):515-37. PubMed ID: 10168093
[TBL] [Abstract][Full Text] [Related]
2. Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.
Henry JA; Rivas CA
Pharmacoeconomics; 1997 May; 11(5):419-43. PubMed ID: 10168031
[TBL] [Abstract][Full Text] [Related]
3. Impact of formulary restrictions on the cost-effectiveness of antidepressant treatment.
Sheehan DV; Wright-Etter PJ
Manag Care Q; 2002; 10(3):21-31. PubMed ID: 12476662
[TBL] [Abstract][Full Text] [Related]
4. A critical review of selected pharmacoeconomic analyses of antidepressant therapy.
Conner TM; Crismon ML; Still DJ
Ann Pharmacother; 1999 Mar; 33(3):364-72. PubMed ID: 10200863
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant treatment for depression: total charges and therapy duration*.
Dobrez DG; Melfi CA; Croghan TW; Kniesner TJ; Obenchain RL
J Ment Health Policy Econ; 2000 Dec; 3(4):187-197. PubMed ID: 11967455
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.
Bosmans JE; Brook OH; van Hout HP; de Bruijne MC; Nieuwenhuyse H; Bouter LM; Stalman WA; van Tulder MW
Pharmacoeconomics; 2007; 25(1):25-37. PubMed ID: 17192116
[TBL] [Abstract][Full Text] [Related]
7. A model to evaluate the cost-effectiveness of oral therapies in the management of patients with major depressive disorders.
Einarson TR; Arikian S; Sweeney S; Doyle J
Clin Ther; 1995; 17(1):136-53. PubMed ID: 7758056
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
Nguyen KH; Gordon LG
Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
[TBL] [Abstract][Full Text] [Related]
9. Differences in the cost of antidepressants across state Medicaid programs.
Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UK.
Lenox-Smith A; Conway P; Knight C
Pharmacoeconomics; 2004; 22(5):311-9. PubMed ID: 15061681
[TBL] [Abstract][Full Text] [Related]
11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
12. The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
Anton SF; Revicki DA
Psychopharmacol Bull; 1995; 31(2):249-58. PubMed ID: 7491376
[TBL] [Abstract][Full Text] [Related]
13. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic issues in the treatment of depression.
Cohen LJ
Formulary; 1995 Sep; 30 Suppl 1():S20-5. PubMed ID: 10151739
[TBL] [Abstract][Full Text] [Related]
15. Trends in the consumption of antidepressant drugs in Lithuania in 2002-2004.
Kadusevicius E; Mikucionyte L; Maciulaitis R; Milvidaite I; Sveikata A
Medicina (Kaunas); 2006; 42(12):1020-9. PubMed ID: 17211111
[TBL] [Abstract][Full Text] [Related]
16. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
Lipsy RJ
Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoeconomic evaluation of antidepressant therapies.
Sarnes MW; Frankum LE
Manag Care; 2004 Jun; 13(6 Suppl Depression):34-41. PubMed ID: 15293769
[TBL] [Abstract][Full Text] [Related]
18. Drug therapy for geriatric depression.
Bressler R; Katz MD
Drugs Aging; 1993; 3(3):195-219. PubMed ID: 8324296
[TBL] [Abstract][Full Text] [Related]
19. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
Hodgkin D; Horgan CM; Creedon TB; Merrick EL; Stewart MT
J Ment Health Policy Econ; 2015 Dec; 18(4):165-73. PubMed ID: 26729008
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
